See more : Alexion Pharmaceuticals, Inc. (AXP.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Shandong Weigao Group Medical Polymer Company Limited (SHWGF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shandong Weigao Group Medical Polymer Company Limited, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Steele Oceanic Corporation (SELR) Income Statement Analysis – Financial Results
- Schneider Electric S.E. (SND.DE) Income Statement Analysis – Financial Results
- Beyond Meat, Inc. (0Q3.F) Income Statement Analysis – Financial Results
- Bohai Automotive Systems CO., LTD. (600960.SS) Income Statement Analysis – Financial Results
- Forward Pharma A/S (FWPAY) Income Statement Analysis – Financial Results
Shandong Weigao Group Medical Polymer Company Limited (SHWGF)
About Shandong Weigao Group Medical Polymer Company Limited
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.23B | 13.62B | 13.15B | 11.35B | 10.36B | 8.81B | 6.29B | 6.73B | 5.92B | 5.28B | 4.61B | 3.69B | 3.18B | 2.46B | 1.88B | 1.51B | 1.10B | 786.93M | 569.99M | 407.82M | 317.94M | 278.25M |
| Cost of Revenue | 6.59B | 6.51B | 5.88B | 4.89B | 3.86B | 3.42B | 2.30B | 2.59B | 2.40B | 2.17B | 1.89B | 1.58B | 1.42B | 1.10B | 877.24M | 756.13M | 594.84M | 451.59M | 335.73M | 244.85M | 185.34M | 171.89M |
| Gross Profit | 6.64B | 7.11B | 7.27B | 6.46B | 6.51B | 5.39B | 3.99B | 4.14B | 3.52B | 3.10B | 2.73B | 2.11B | 1.76B | 1.36B | 1.00B | 758.23M | 500.27M | 335.34M | 234.26M | 162.98M | 132.60M | 106.35M |
| Gross Profit Ratio | 50.21% | 52.23% | 55.27% | 56.92% | 62.77% | 61.18% | 63.45% | 61.46% | 59.40% | 58.82% | 59.11% | 57.26% | 55.34% | 55.21% | 53.30% | 50.07% | 45.68% | 42.61% | 41.10% | 39.96% | 41.71% | 38.22% |
| Research & Development | 592.85M | 546.55M | 492.13M | 411.40M | 406.36M | 311.16M | 273.83M | 302.68M | 292.66M | 238.10M | 208.92M | 170.59M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.25B | 1.12B | 1.11B | 1.02B | 986.24M | 929.61M | 419.54M | 731.46M | 393.32M | 324.33M | 314.00M | 212.89M | 285.78M | 262.19M | 180.94M | 137.68M | 88.05M | 59.76M | 40.11M | 29.61M | 21.98M | 21.38M |
| Selling & Marketing | 2.58B | 2.43B | 2.66B | 2.64B | 2.78B | 2.44B | 1.92B | 1.84B | 1.54B | 1.42B | 1.16B | 874.32M | 633.44M | 501.32M | 321.32M | 208.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.83B | 3.54B | 3.77B | 3.66B | 3.77B | 3.37B | 2.34B | 2.57B | 1.94B | 1.74B | 1.48B | 1.09B | 919.22M | 763.51M | 502.26M | 346.43M | 88.05M | 59.76M | 40.11M | 29.61M | 21.98M | 21.38M |
| Other Expenses | 0.00 | -124.70M | -113.21M | -101.74M | -97.04M | -74.79M | -62.77M | 40.02M | 10.30M | 7.92M | 2.52M | 3.15M | 2.56B | -104.16M | 109.37M | 55.98M | 72.56M | 29.13M | -4.19M | -11.85M | -11.63M | -2.89M |
| Operating Expenses | 4.35B | 3.97B | 4.15B | 3.97B | 4.08B | 3.60B | 2.55B | 2.84B | 2.20B | 1.95B | 1.64B | 1.20B | 877.01M | 659.35M | 439.26M | 268.35M | 240.75M | 175.13M | 127.49M | 90.21M | 71.11M | 58.23M |
| Cost & Expenses | 10.83B | 10.47B | 10.03B | 8.85B | 7.94B | 7.02B | 4.85B | 5.44B | 4.61B | 4.13B | 3.52B | 2.78B | 2.30B | 1.76B | 1.32B | 1.02B | 835.59M | 626.71M | 463.22M | 335.06M | 256.45M | 230.12M |
| Interest Income | 235.68M | 180.29M | 143.94M | 114.25M | 129.35M | 170.81M | 72.24M | 45.10M | 65.08M | 43.84M | 6.52M | 20.49M | 6.45M | 0.00 | 5.99M | 3.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 272.97M | 191.40M | 140.40M | 178.94M | 396.74M | 284.41M | 23.88M | 56.76M | 44.50M | 22.71M | 8.96M | 4.68M | 1.14M | 9.66M | 4.00M | 30.23M | 17.87M | 0.00 | 4.19M | 3.84M | 6.46M | 0.00 |
| Depreciation & Amortization | 911.70M | 803.14M | 736.67M | 708.96M | 611.20M | 562.56M | 365.00M | 349.17M | 316.37M | 244.48M | 187.96M | 128.34M | 97.71M | 93.48M | 74.76M | 60.25M | 48.04M | 43.31M | 23.86M | 16.01M | 11.47M | 8.69M |
| EBITDA | 3.55B | 4.38B | 3.75B | 3.30B | 3.27B | 2.62B | 1.91B | 1.72B | 1.70B | 1.54B | 1.30B | 1.26B | 3.69B | 991.02M | 783.13M | 614.99M | 307.55M | 203.52M | 130.63M | 88.78M | 72.96M | 56.82M |
| EBITDA Ratio | 26.86% | 32.04% | 30.72% | 29.07% | 32.03% | 29.62% | 30.70% | 25.61% | 28.65% | 27.00% | 28.29% | 34.13% | 116.06% | 40.24% | 41.72% | 40.58% | 28.08% | 25.86% | 22.92% | 21.77% | 22.95% | 20.42% |
| Operating Income | 2.18B | 3.56B | 3.32B | 2.61B | 2.71B | 2.05B | 1.57B | 1.38B | 1.34B | 1.30B | 1.05B | 962.37M | 3.59B | 700.35M | 567.99M | 489.88M | 259.52M | 160.21M | 106.77M | 81.72M | 68.44M | 53.61M |
| Operating Income Ratio | 16.48% | 26.15% | 25.21% | 22.98% | 26.13% | 23.24% | 24.90% | 20.54% | 22.69% | 24.60% | 22.83% | 26.09% | 112.99% | 28.44% | 30.24% | 32.35% | 23.70% | 20.36% | 18.73% | 20.04% | 21.53% | 19.27% |
| Total Other Income/Expenses | 188.79M | 184.69M | -195.65M | 18.93M | -456.09M | -271.58M | -39.02M | 80.67M | 50.92M | 151.25M | -509.04M | 271.55M | -1.14M | 187.54M | 136.97M | 34.20M | 72.56M | 29.13M | -4.19M | -11.85M | -11.63M | -2.89M |
| Income Before Tax | 2.37B | 3.32B | 2.84B | 2.50B | 2.25B | 1.78B | 1.53B | 1.31B | 1.34B | 1.28B | 544.15M | 1.13B | 3.59B | 887.88M | 704.96M | 524.08M | 332.07M | 189.35M | 102.58M | 69.87M | 56.80M | 50.73M |
| Income Before Tax Ratio | 17.91% | 24.36% | 21.61% | 22.00% | 21.68% | 20.15% | 24.28% | 19.53% | 22.56% | 24.17% | 11.80% | 30.53% | 112.95% | 36.06% | 37.53% | 34.61% | 30.32% | 24.06% | 18.00% | 17.13% | 17.87% | 18.23% |
| Income Tax Expense | 307.59M | 424.27M | 415.09M | 345.64M | 327.14M | 258.43M | 224.40M | 176.75M | 186.65M | 180.84M | 156.48M | 129.81M | 124.47M | 85.53M | 71.78M | 38.98M | 2.73M | 6.75M | 2.00K | 3.04M | 4.57M | 5.30M |
| Net Income | 2.00B | 2.76B | 2.28B | 2.09B | 1.84B | 1.47B | 1.30B | 1.11B | 1.11B | 1.08B | 387.98M | 996.49M | 3.46B | 799.07M | 633.86M | 482.39M | 329.34M | 182.60M | 102.58M | 65.89M | 50.45M | 43.53M |
| Net Income Ratio | 15.13% | 20.30% | 17.31% | 18.39% | 17.80% | 16.72% | 20.71% | 16.43% | 18.80% | 20.56% | 8.41% | 27.01% | 108.85% | 32.45% | 33.74% | 31.85% | 30.07% | 23.20% | 18.00% | 16.16% | 15.87% | 15.64% |
| EPS | 0.44 | 0.60 | 0.51 | 0.46 | 0.41 | 0.33 | 0.29 | 0.25 | 0.25 | 0.24 | 0.09 | 0.22 | 0.78 | 0.19 | 0.07 | 0.12 | 0.08 | 0.05 | 0.03 | 0.02 | 0.02 | 0.02 |
| EPS Diluted | 0.44 | 0.60 | 0.50 | 0.46 | 0.41 | 0.33 | 0.29 | 0.25 | 0.25 | 0.24 | 0.09 | 0.22 | 0.78 | 0.19 | 0.07 | 0.12 | 0.08 | 0.05 | 0.03 | 0.02 | 0.02 | 0.02 |
| Weighted Avg Shares Out | 4.51B | 4.51B | 4.50B | 4.49B | 4.48B | 4.48B | 4.48B | 4.48B | 4.48B | 4.48B | 4.48B | 4.48B | 4.42B | 4.31B | 8.61B | 3.99B | 3.95B | 3.80B | 3.68B | 3.29B | 2.52B | 2.49B |
| Weighted Avg Shares Out (Dil) | 4.52B | 4.53B | 4.52B | 4.49B | 4.48B | 4.48B | 4.48B | 4.48B | 4.48B | 4.48B | 4.48B | 4.48B | 4.42B | 4.31B | 8.61B | 3.99B | 3.95B | 3.80B | 3.68B | 3.29B | 2.52B | 2.49B |
Source: https://incomestatements.info
Category: Stock Reports